Transnational Pharmacoeconomic Policy: Analysis of EEA and Switzerland using World Bank Data
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: ABRAHAM, Ivo (UNIVERSITY OF ARIZONA, Pharmacy Practice and Science, Tucson, United States)
- Co-author(s): Chinmayee Katragadda:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States|Preshit Ambade:College of Public Health,UNIVERSITY OF ARIZONA,Tucson,United States|Diana Sun:,Genentech,San Francisco,United States|Dhfer AlShayban:,Ministry of Health,Riyadh,Saudi Arabia|Ivo Abraham:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States
Historically, pharmacoeconomic policy decision making has occurred at the national level but moving towards harmonization of pharmaceutical policy will help improve impact of pharmaceutical goods and services on patients.
Our study used World Bank database for EEA countries and Switzerland s’ health-related data from 1995-2013 with Average annual.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.